Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

This randomised phase II study evaluates the safety and efficacy profile of uracil/tegafur/leucovorin combined with irinotecan (TEGAFIRI) or with oxaliplatin (TEGAFOX). One hundred and forty-three patients with measurable, non-resectable metastatic colorectal cancer were randomised in a multicentre...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajetta, E, Di Bartolomeo, M, Buzzoni, R, Mariani, L, Zilembo, N, Ferrario, E, Lo Vullo, S, Aitini, E, Isa, L, Barone, C, Jacobelli, S, Recaldin, E, Pinotti, G, Iop, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360030/
https://www.ncbi.nlm.nih.gov/pubmed/17245343
http://dx.doi.org/10.1038/sj.bjc.6603493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360030/
https://www.ncbi.nlm.nih.gov/pubmed/17245343
http://dx.doi.org/10.1038/sj.bjc.6603493

Ejemplares similares